PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Innovative research aims to improve wound healing and cancer therapy

Freiburg researcher Priscilla Briquez receives ERC Starting Grant for innovative approach to protein engineering

Innovative research aims to improve wound healing and cancer therapy
2023-10-27
(Press-News.org)

Jun.-Prof. Dr. Priscilla Briquez, junior professor at the Department of General and Visceral Surgery at the Freiburg University Medical Center and member of the Medical Faculty at the University of Freiburg, has received a European Research Council (ERC) Starting Grant from the European Commission. Her DRESSCODE project will receive a total of 1.5 million euros funding for five years. The project focuses on modifying proteins and developing new disease therapies.

“This support is a major opportunity for me to put together my own team and drive forward my research,” says Briquez. The focus of the project is on equipping protein cell membranes with therapeutic receptors. This produces cells which can perform specific healing functions, such as targeted bonding to medicines or pathogens. “The research project opens up new, significant opportunities for both regenerative medicine and cancer immunotherapy,” says Prof. Dr. Lutz Hein, Dean of the Medical Faculty of the University of Freiburg.

Innovations for wound healing and cancer immunotherapy

In the field of regenerative medicine, Briquez’s research approach can specifically alter the vascular endothelial growth factor (VEGF) receptor-2. This promotes the formation of blood vessels in chronic wounds and assists wound healing. In connection with cancer immunotherapy the project is researching the development of chimeric antigen receptors (CAR) on T-cells. These are receptors that are placed on immune cells in order to identify and attack cancer cells.

Briquez gained her PhD in 2016 at the Ecole Polytechnique Federale of Lausanne (EPFL), where she investigated the development of therapeutic proteins and biomaterials for wound healing. After that she was a postdoc at the Pritzker School of Molecular Engineering of the University of Chicago. There, she devoted herself to the field of molecular immunoengineering and cancer immunotherapy, before moving to the Department of General and Visceral Surgery at the Freiburg University Medical Center in 2021 where she was appointed junior professor.

With its Starting Grant funding line the ERC supports junior researchers who have already done outstanding work and who have the potential to assume a leading role in research.

Contact:
Corporate Communications
Freiburg University Medical Center
Tel. +49 761 270-84830
email: kommunikation@uniklinik-freiburg.de

University and Science Communication
University of Freiburg
Tel. +49 761 203-4302
email: kommunikation@zv.uni-freiburg.de

END


[Attachments] See images for this press release:
Innovative research aims to improve wound healing and cancer therapy Innovative research aims to improve wound healing and cancer therapy 2

ELSE PRESS RELEASES FROM THIS DATE:

Action plan for better data on migration and health

Action plan for better data on migration and health
2023-10-27
Despite rising global mobility, the state of migrant and refugee health data in European health systems is a concern, a new study shows. The analysis by an international coalition of universities, UN organizations, government representatives, and European institutions published in the journal The Lancet Regional Health Europe reveals that coverage of migrant and refugee data remains inconsistent and of suboptimal quality. According to the study this issue is not due to a lack of knowledge or technological resources ...

FDA approves muscular dystrophy drug built on Children’s National research 

2023-10-27
WASHINGTON (October 27, 2023) – Boys with Duchenne muscular dystrophy (DMD) have a clinically proven, new treatment option with the Food and Drug Administration’s approval Thursday of vamorolone, a steroidal-type, anti-inflammatory drug developed based on research performed at Children’s National Hospital.    Created by ReveraGen BioPharma Inc., vamorolone has a molecular structure similar to traditional corticosteroids, which are currently used to treat DMD. Yet its structure was found to be chemically different enough to reduce unwanted side effects, including brittle bones and reduced stature. Nearly two decades ago, ReveraGen leaders – President and ...

Electrodes with hollow nanotubes improve performance of potassium-ion batteries

Electrodes with hollow nanotubes improve performance of potassium-ion batteries
2023-10-27
Researchers who are working to find alternatives to lithium-ion batteries have turned their attention to potassium-ion batteries. Potassium is an abundant resource and the technology functions in much the same way as lithium-ion batteries, but these batteries have not been developed at a large scale because the ionic radius causes problems in energy storage and substandard electrochemical performance.   To solve this problem, researchers are considering NiCo2Se4, a bimetallic selenide, to create sphere-shaped electrodes. The spheres are constructed with NiCo2Se4 nanotubes, which improve ...

USDA grant will help MU researchers address opioid epidemic in rural Missouri

USDA grant will help MU researchers address opioid epidemic in rural Missouri
2023-10-27
COLUMBIA, Mo. -- Childhood trauma is a key risk factor for future substance use disorder, overdose, and suicide. This is particularly problematic in rural areas where children experience higher rates of adverse childhood experiences (ACEs). ACEs are commonly defined as physical and emotional abuse and neglect, sexual abuse, parental separation or divorce, intimate partner violence, and having household members with serious mental illness, substance use disorder, or a history of incarceration. Now, a three-year, U.S. Department of Agriculture (USDA) grant awarded to the University of Missouri will help virtually train various members of the workforce — ...

UiB researchers solve protein mystery

UiB researchers solve protein mystery
2023-10-27
Proteins are key to all processes in our cells and understanding their functions and regulation is of major importance. “For many years, we have known that nearly all human proteins are modified by a specific chemical group, but its functional impact has remained undefined”, says professor Thomas Arnesen at the Department of Biomedicine, University of Bergen. He explains: “One of the most common protein modifications in human cells is N-terminal acetylation, which is an addition of a small chemical group (acetyl) at the starting tip (N-terminus) of a protein. The ...

Protein root discovery seals future of climate proof plants

2023-10-27
Researchers have discovered a protein that seals plant roots to regulate the uptake of nutrients and water from the soil, the discovery could help develop climate proof crops that require less water and chemical fertilizers. Researchers from the University of Nottingham identified new components of the lignin barrier in plant roots and the specific function of dirigent proteins (DPs), located in the root endodermis that control water and nutrient uptake. Their findings have been published today in Science Direct. Plant roots function by absorbing ...

A relational framework for microbiome research that includes Indigenous communities

2023-10-27
Research on the trillions of microorganisms that make up a person’s microbiome can lead to medical breakthroughs to treat diseases like inflammatory bowel syndrome and diabetes. According to Alyssa Bader, a Tsimshian Assistant Professor in the Department of Anthropology at McGill University, microbiome samples from Indigenous communities have the potential to further Western medicine, but those same communities often have been excluded from the research process and may miss out on the benefits that result from their contributions to science. ...

City of Hope part of successful international Phase 3 clinical trial evaluating sotorasib medication combination for patients with metastatic colorectal cancer

City of Hope part of successful international Phase 3 clinical trial evaluating sotorasib medication combination for patients with metastatic colorectal cancer
2023-10-27
LOS ANGELES — An international Phase 3 clinical trial found that metastatic colorectal cancer patients with a rare genetic tumor mutation called KRAS G12C experienced superior progression-free survival rates compared to standard of care when offered a combination treatment of KRAS inhibitor sotorasib and monoclonal antibody panitumumab. City of Hope, one of the largest cancer research and treatment organizations in the United States, was a participating site and a City of Hope researcher is the lead author of the The New England Journal of Medicine study published this week. Standard ...

Team synthesizes a new polyoxometalate-based metal-organic complex

Team synthesizes a new polyoxometalate-based metal-organic complex
2023-10-27
A research team has synthesized a new polyoxometalate-based metal-organic complex that they then tested as a catalyst for the oxidation reactions of various sulfides. They found that the complex possesses excellent catalytic performance, good reusability, and structural stability.   The team’s work is published in the journal Polyoxometalates on October 19, 2023.   Scientists in many fields have explored the selective oxidation of sulfides to sulfoxides. Sulfoxides are organic compounds that contain sulfur and oxygen. These sulfoxides are high value-added chemicals in pharmaceuticals, agrochemistry, ...

The sunscreen paradox: McGill University researchers warn of ‘false sense of security’

2023-10-27
Sunscreen usage is climbing, but so are melanoma and skin cancer rates: this, researchers say, is the sunscreen paradox. “The problem is that people use sunscreen as a ‘permission slip’ to tan,” said Dr. Ivan Litvinov, an Associate Professor in the Department of Medicine and Chair of the Dermatology Division at McGill University and co-author with Dr. Sandra Peláez, Dr. Richie Jeremian and Dr. Pingxing Xie of two recent studies that explore the sunscreen paradox. “People think they are protected from skin cancer ...

LAST 30 PRESS RELEASES:

Radiopharmaceutical therapy offers promise for people with tough-to-treat meningioma brain tumors

American Academy of Pediatrics promotes shared reading starting in infancy as a positive parenting practice with lifelong benefits

Unexpected human behaviour revealed in prisoner's dilemma study: Choosing cooperation even after defection

Distant relatedness in biobanks harnessed to identify undiagnosed genetic disease

UCLA at ASTRO: Predicting response to chemoradiotherapy in rectal cancer, 2-year outcomes of MRI-guided radiotherapy for prostate cancer, impact of symptom self-reporting during chemoradiation and mor

Estimated long-term benefits of finerenone in heart failure

MD Anderson launches first-ever academic journal: Advances in Cancer Education & Quality Improvement

Penn Medicine at the 2024 ASTRO Annual Meeting

Head and neck, meningioma research highlights of University of Cincinnati ASTRO abstracts

Center for BrainHealth receives $2 million match gift from Adm. William McRaven (ret.), recipient of Courage & Civility Award

Circadian disruption, gut microbiome changes linked to colorectal cancer progression

Grant helps UT develop support tool for extreme weather events

Autonomous vehicles can be imperfect — As long as they’re resilient

Asteroid Ceres is a former ocean world that slowly formed into a giant, murky icy orb

McMaster researchers discover what hinders DNA repair in patients with Huntington’s Disease

Estrogens play a hidden role in cancers, inhibiting a key immune cell

A new birthplace for asteroid Ryugu

How are pronouns processed in the memory-region of our brain?

Researchers synthesize high-energy-density cubic gauche nitrogen at atmospheric pressure

Ancient sunken seafloor reveals earth’s deep secrets

Automatic speech recognition learned to understand people with Parkinson’s disease — by listening to them

Addressing global water security challenges: New study reveals investment opportunities and readiness levels

Commonly used drug could transform treatment of rare muscle disorder

Michael Frumovitz, M.D., posthumously honored with Julie and Ben Rogers Award for Excellence

NIH grant supports research to discover better treatments for heart failure

Clinical cancer research in the US is increasingly dominated by pharmaceutical industry sponsors, study finds

Discovery of 3,775-year-old preserved log supports ‘wood vaulting’ as a climate solution

Preterm births are on the rise, with ongoing racial and economic gaps

Menopausal hormone therapy use among postmenopausal women

Breaking the chain of intergenerational violence

[Press-News.org] Innovative research aims to improve wound healing and cancer therapy
Freiburg researcher Priscilla Briquez receives ERC Starting Grant for innovative approach to protein engineering